Assertion: thrombotic thrombocytopenic purpura | /r/HasProperty | attp
Facets:
Source sentences:
text: (NASDAQ:SNY) reported on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) for Cablivi (caplacizumab-yhdp) in combination with plasma exchange and immunosuppression for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults.
text: It is indicated for acquired thrombotic thrombocytopenic purpura (aTTP) in combination with plasma exchange and immunosuppressive therapy.